Grassadonia, A.; Cioffi, P.; Simiele, F.; Iezzi, L.; Zilli, M.; Natoli, C.
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies. Cancers 2013, 5, 919-942.
https://doi.org/10.3390/cancers5030919
AMA Style
Grassadonia A, Cioffi P, Simiele F, Iezzi L, Zilli M, Natoli C.
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies. Cancers. 2013; 5(3):919-942.
https://doi.org/10.3390/cancers5030919
Chicago/Turabian Style
Grassadonia, Antonino, Pasquale Cioffi, Felice Simiele, Laura Iezzi, Marinella Zilli, and Clara Natoli.
2013. "Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies" Cancers 5, no. 3: 919-942.
https://doi.org/10.3390/cancers5030919
APA Style
Grassadonia, A., Cioffi, P., Simiele, F., Iezzi, L., Zilli, M., & Natoli, C.
(2013). Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies. Cancers, 5(3), 919-942.
https://doi.org/10.3390/cancers5030919